
Intelligent Bio Solutions
Intelligent Bio Solutions: Rapid, fingertip-based diagnostic testing for drug abuse detection.

Intelligent Bio Solutions: Rapid, fingertip-based diagnostic testing for drug abuse detection.
Intelligent Bio Solutions, founded with a mission to revolutionize drug testing, focuses on providing rapid, non-invasive diagnostic solutions. The company’s flagship product is a cutting-edge device that detects drug abuse by analyzing fingerprints, capable of identifying substances such as cannabis, methamphetamine, opiates, and cocaine within 16 hours prior to testing. Their market focus includes sectors requiring quick and reliable drug screening, such as transportation and infrastructure.
Notable affiliated individuals include key executives with extensive experience in medical technology and diagnostics. The company has attracted significant investment and partnerships, including recent collaborations with major European transport and infrastructure providers. Key achievements include the successful implementation of a strategic reorganization plan to support global growth and the adoption of their fingerprint drug screening technology by numerous accounts. Intelligent Bio Solutions is making a substantial impact by enhancing the efficiency and accuracy of drug testing processes worldwide.
Companies similar to Intelligent Bio Solutions include American Bio Medica, Psychemedics, Maxim Biotech and American Clinical Solutions.
Intelligent Bio Solutions was founded in 2017.
Intelligent Bio Solutions' headquarters is located in New York City, NY, US.
Intelligent Bio Solutions' most recent funding round was for $4M (USD) in October 2023.
As of Oct 2, 2023, Intelligent Bio Solutions has disclosed funding of $5.4M (USD). Undisclosed round amounts are excluded.
Intelligent Bio Solutions has 15,000 employees as of Feb 5, 2024.

American Clinical Solutions
acslabtest.com